InnovAge Holding Corp (INNV)
Official siteHEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ
Market Cap: $1.29B
Last updated: Nov 17, 2026 at 11:05 AM ET
InnovAge Holding Corp (INNV) P/E Ratio & Valuation History
InnovAge Holding (INNV) trades at 20.4x trailing earnings and 1.3x sales. Its P/S of 1.3x is above its 5-year median of 1.0x. Its forward P/E is 13.7x.
Current Multiples
Its forward P/E is below its trailing P/E, which implies earnings per share about 48.9% higher over the next year. Its free cash flow yield is 5.8%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 20.4x |
| Forward P/E | 13.7x |
| Price to sales | 1.3x |
| Price to book | 5.1x |
| EV/EBITDA | 32.7x |
| Price to FCF | 17.1x |
| EV/FCF | 16.3x |
| PEG | N/A |
| FCF yield | 5.8% |
Historical Medians
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/S | 1.3x | 1.0x | N/A |
| P/B | 5.1x | 2.7x | N/A |
Valuation History
Over the 5 year ends shown, its P/S ranged from 0.7x in 2024 to 1.4x in 2022.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $5.19 | 28.8x | 0.8x | 2.7x |
| 2024 | $3.93 | N/A | 0.7x | 2.1x |
| 2023 | $6.00 | N/A | 1.1x | 2.9x |
| 2022 | $7.18 | N/A | 1.4x | 3.1x |
| 2021 | $5.00 | 21.7x | 1.0x | 2.0x |
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About INNV
What is INNV's forward P/E ratio?
InnovAge Holding has a forward P/E ratio of 13.7x.
Is INNV stock overvalued?
GNG's valuation label for INNV is Fairly valued.
What is INNV's price to sales ratio?
InnovAge Holding has a price to sales ratio of 1.3x.
INNV pages: Overview, Earnings, Forecast, Financials, Valuation